The Community Guide

- gsearch

Search Results

Narrow Results:

2023 2
2019 1
2018 1

eDOT Study Team 1

New York City, New York 1

Journal Article 4

1 - 4 of 4 Results

Refine Results

Refine Results:

Cost savings associated with video directly observed therapy for treatment of tuberculosis

CITE Title : Cost savings associated with video directly observed therapy for treatment of tuberculosis Personal Author(s) : Lam, C. K.;Fluegge, K.;Macaraig, M.;Burzynski, J.; Published Date : 01 2019 Source : Int J Tuberc Lung Dis. 23(11):1149-1154 URL : https://stacks.cdc.gov/view/cdc/85755 Lam, C. K. et al. (2019). Cost savings associated with video directly observed therapy for treatment of tuberculosis. 23(11). Lam, C. K. et al. "Cost savings associated with video directly observed therapy for treatment of tuberculosis" 23, no. 11 (2019) Lam, C. K. et al. "Cost savings associated with video directly observed therapy for treatment of tuberculosis" vol. 23, no. 11, 2019 Export RIS Citation Information.

:

Lam, C. K. ;

Fluegge, K.

01 2019 | Int J Tuberc Lung Dis. 23(11):1149-1154

:

OBJECTIVE:To calculate the per-session and annual direct program costs to implement directly observed therapy (DOT) for tuberculosis treatment and to ...
Improved treatment completion with shorter treatment regimens for latent tuberculous infection

CITE Title : Improved treatment completion with shorter treatment regimens for latent tuberculous infection Personal Author(s) : Macaraig, M. M.;Jalees, M.;Lam, C.;Burzynski, J.; Published Date : November 2018 Source : Int J Tuberc Lung Dis. 22(11):1344-1349 URL : https://stacks.cdc.gov/view/cdc/61785 Macaraig, M. M. et al. (2018). Improved treatment completion with shorter treatment regimens for latent tuberculous infection. 22(11). Macaraig, M. M. et al. "Improved treatment completion with shorter treatment regimens for latent tuberculous infection" 22, no. 11 (2018) Macaraig, M. M. et al. "Improved treatment completion with shorter treatment regimens for latent tuberculous infection" vol. 22, no. 11, 2018 Export RIS Citation Information.

:

Macaraig, M. M. ;

Jalees, M.

November 2018 | Int J Tuberc Lung Dis. 22(11):1344-1349

:

SETTING:Four New York City (NYC) Health Department tuberculosis (TB) clinics.OBJECTIVE:To assess the effectiveness of preferentially offering two shor...
Adverse events among persons with TB using in-person vs. electronic directly observed therapy

CITE Title : Adverse events among persons with TB using in-person vs. electronic directly observed therapy Personal Author(s) : Salerno, M. M.;Burzynski, J.;Mangan, J. M.;Hill, A.;Rey deCastro, B.;Goswami, N. D.;Lam, C. K.;Macaraig, M.;Schluger, N. W.;Vernon, A. A.; Published Date : 8 01 2023;8-01-; Source : Int J Tuberc Lung Dis. 27(11):833-840 URL : https://stacks.cdc.gov/view/cdc/142648 Salerno, M. M. et al. (2023). Adverse events among persons with TB using in-person vs. electronic directly observed therapy. 27(11). Salerno, M. M. et al. "Adverse events among persons with TB using in-person vs. electronic directly observed therapy" 27, no. 11 (2023) Salerno, M. M. et al. "Adverse events among persons with TB using in-person vs. electronic directly observed therapy" vol. 27, no. 11, 2023 Export RIS Citation Information.

:

Salerno, M. M. ;

Burzynski, J.

8 01 2023 | Int J Tuberc Lung Dis. 27(11):833-840

:

BACKGROUND :We evaluated patient safety within a randomized crossover trial comparing electronic directly observed therapy (eDOT) to in-person DOT (ip...
Challenges associated with electronic and in-person directly observed therapy during a randomized trial

CITE Title : Challenges associated with electronic and in-person directly observed therapy during a randomized trial Personal Author(s) : Mangan, J. M.;Burzynski, J.;Rey deCastro, B.;Salerno, M. M.;Lam, C. K.;Macaraig, M.;Reaves, M.;Kiskadden-Bechtel, S.;Bowers, S.;Sathi, C.;Dias, M. P.;Goswami, N. D.;Vernon, A.; Corporate Authors(s) : eDOT Study Team Published Date : 4 01 2023;4-01-; Source : Int J Tuberc Lung Dis. 27(4):298-307 URL : https://stacks.cdc.gov/view/cdc/147641 Mangan, J. M. et al. (2023). Challenges associated with electronic and in-person directly observed therapy during a randomized trial. 27(4). Mangan, J. M. et al. "Challenges associated with electronic and in-person directly observed therapy during a randomized trial" 27, no. 4 (2023) Mangan, J. M. et al. "Challenges associated with electronic and in-person directly observed therapy during a randomized trial" vol. 27, no. 4, 2023 Export RIS Citation Information.

:

Mangan, J. M. ;

Burzynski, J.

4 01 2023 | Int J Tuberc Lung Dis. 27(4):298-307

:

BACKGROUND:Electronic directly observed therapy (eDOT) has been proposed as an alternative to traditional in-person DOT (ipDOT) for monitoring TB trea...